Source: FirstWord Pharma

ZielBio: ZielBio to Present New Data Demonstrating Preclinical Efficacy of ZB131 in Cholangiocarcinoma at AACR Annual Meeting 2022

ZB131 is a first-in-class humanized monoclonal antibody targeted to cancer specific plectin New, preclinical research to be presented at AACR Annual Meeting 2022 shows ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Alan S. Bash's photo - CEO of ZielBio

CEO

Alan S. Bash

CEO Approval Rating

90/100

Read more